Inventor

Jon M. Wigginton

Inventor

Collegeville, PA, US

Overview

2017–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes22%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C07KPeptides22%

G01NInvestigating or analysing materials by determining their chemical or physical properties18%

Y02ATechnologies for adaptation to climate change18%

PatentTitleYear

11,078,279Combination therapy for the treatment of cancer2021 10,688,180Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer2020 10,604,575Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2020 10,584,170Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2020 10,577,423Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2020 10,323,093Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,323,092Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,316,090Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,316,091Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,308,714Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,266,594Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,266,596Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,266,595Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2019 10,138,299Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2018 10,072,082Cancer immunotherapy by disrupting PD-1/PD-L1 signaling2018 9,856,320'Cancer immunotherapy by disrupting PD-1/PD-L1 signaling'2018 9,789,182'Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2020Patents assigned to BRISTOL MYERS SQUIBB CO (16)· patent assignee history

2017–2020Patents assigned to INNATE PHARMA (2)· patent assignee history

2017–2020Based in Collegeville, PA, US· patent location history

2018–2021Based in Rockville, MD, US· patent location history

2021Patents assigned to MACROGENICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BRISTOL MYERS SQUIBB CO	16	2017–2020
INNATE PHARMA	2	2017–2020
MACROGENICS INC	1	2021

Locations

Location	Patents	Span
Collegeville, Pennsylvania, US	15	2017–2020
Rockville, Maryland, US	2	2018–2021